Three URs (ARHGAP21, KLF4, TBK1), among those that discriminated responding and non responding patients in the baseline tumor samples, lost significance in subsequent biopsies, possible reflecting the shift in the transcriptomic programs of the neoplastic lesions occurring as result of therapy. The gene discussed is KLF4; the disease is neoplasm.